Neonatal seizures. Convulsions of newborn
Conditions
Interventions
Intervention 1: In the intervention group, patients are treated with levetiracetam injection (500 mg / 5ml STRAGEN pharmaceutical company) at a loading dose of 30 mg / kg and infusion rate of 2 mg / k
Sponsors
Mashhad University of Medical Sciences
Eligibility
Sex/Gender
All
Age
No minimum to 1 Months
Inclusion criteria
Inclusion criteria: pregnancy age of 34 weeks or more Weight of greater than or equal to 2 kg Hospitalization due to seizure of unknown cause in the pediatric emergency room or neonatal intensive care unit
Exclusion criteria
Exclusion criteria: underlying anomaly Systemic metabolic disease Structural disorders of the brain Previous history of anticonvulsant medication Presence of drug allergies including urticaria, flushing, angioedema, anaphylaxis
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Control of seizures after drug injection. Timepoint: 15 minutes after administration of the drug in cases of seizures and within 24 hours in cases where the seizures have stopped. Method of measurement: Stoping seizure movements clinically. | — |
Secondary
| Measure | Time frame |
|---|---|
| The need or lack of need to continue anticonvulsant medication at discharge. Timepoint: at the time of discharge. Method of measurement: Diagnosis of the treating physician. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactGholam ali Maamouri
Mashhad University of Medical Sciences
Outcome results
None listed